Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Sequana Medical NV

Sequana Medical announces Special General Meeting of Shareholders on 26 June 2023
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces results of Annual General Meeting of Shareholders
From Sequana Medical NV
Via GlobeNewswire
Transparency Notifications from Shareholders
From Sequana Medical NV
Via GlobeNewswire
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces FDA clearance of IND application for DSR® 2.0 for treatment of congestive heart failure
From Sequana Medical NV
Via GlobeNewswire
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces additional patents for DSR® in China and the United States
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces results of Extraordinary General Meeting of Shareholders
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces 2022 Full Year Results and 2023 Outlook
From Sequana Medical NV
Via GlobeNewswire
Transparency Notifications from Shareholders
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical Notice of 2022 Full Year Results and Business Update
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces grant of additional DSR® patent in United States
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces Extraordinary General Meeting of Shareholders on 10 February 2023
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical to present at Jefferies London Healthcare Conference
From Sequana Medical NV
Via GlobeNewswire
Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)
From Sequana Medical NV
Via GlobeNewswire
Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®
From Sequana Medical NV
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.